Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-03-22 Sale |
2024-03-22 5:03 pm |
CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer |
20,125 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-11 Option Award |
2025-04-15 4:16 pm |
N/A 2035-04-11 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2025-01-21 Option Award |
2025-01-23 6:19 pm |
N/A 2035-01-20 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer |
600,000 | $0 | 600,000 (Direct) |
View |
2024-01-24 Option Award |
2024-01-26 6:33 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer |
94,875 | $0 | 94,875 (Direct) |
View |
2023-05-22 Option Award |
2023-05-22 5:13 pm |
N/A 2033-05-21 |
CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer |
360,000 | $0 | 360,000 (Direct) |
View |